Cobas assay

Ended Awarded

Contract number
HT009022FG0440033
Awardee
Awarding agency
Obligated
$25,000

Award facts

Contract value 100% obligated
$24,999.55 Current and potential, with all options
Completion date 100% complete
Current and potential, with all options
NAICS code
334516 Analytical Laboratory Instrument Manufacturing
PSC
6640 Laboratory Equipment And Supplies
Set-aside
No set-aside
Competition
Competed under SAP · 1 offer Simplified Acquisition
Pricing
Firm Fixed Price
Place of performance
Castleton, IN 46256, USA

Award details come from SAM.gov/FPDS.

About this award

Roche Diagnostics Corporation was awarded a firm fixed price blanket purchase agreement (BPA) call contract by the Defense Health Agency on April 15, 2022. The contract has a potential value of $24,999.55 to provide COBAS assays with no set-aside designation applied. Performance will occur in Castleton, Indiana through September 30, 2022. As the healthcare arm of the Department of Defense, this award supports the Defense Health Agency's mission to provide health care support and services to military members, veterans, and their families through contracts like this for laboratory testing supplies.

Quick answers

Who was awarded contract HT009022FG0440033?

HT009022FG0440033 was awarded to Roche Diagnostics Corporation by Defense Health Agency (Department of Defense) on April 15, 2022.

How much is contract HT009022FG0440033 worth?

The government has obligated $25,000 on HT009022FG0440033.

Is contract HT009022FG0440033 an order under another contract?

Yes. HT009022FG0440033 is a BPA call under FA700020A0003, a blanket purchase agreement.

Was contract HT009022FG0440033 competed?

The extent of competition for HT009022FG0440033 was competed under sap. The government received 1 offer.

On GovTribe

See this award's full record

  • Every transaction and funding action
  • The awardee's other awards and teaming partners
  • Similar awards and recompete opportunities
  • Ask GovTribe AI about this award